Pharmaceutical Manufacturer Pays $3.5 Million for Producing “Adulterated Drugs” and Connected FCA Violation
Department of Justice – A generic drug manufacturer in Pennsylvania has pleaded guilty to introducing adulterated drugs into interstate commerce, and violating the FCA by failing to exercise appropriate controls preventing this.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year